NCT02365480View on ClinicalTrials.gov

Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 16, 2016

Primary Completion Date

February 16, 2018

Study Completion Date

December 13, 2019

Conditions
Ulcerative Colitis
Interventions
DRUG

Berberine Chloride

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Placebo Administration

Given PO

Trial Locations (2)

60611

Northwestern University, Chicago

710032

Fourth Military Medical University, Xi'an

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT02365480 - Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission | Biotech Hunter | Biotech Hunter